Quantitative expression analysis in peripheral blood of patients with chronic myeloid leukaemia: Correlation between HMGA2 expression and white blood cell count

References

• Reeves R, Nissen M S. The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J Biol Chem 1990; 265: 8573–8582
   PubMed Web of Science ®Google Scholar
• Bustin M, Reeves R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol 1996; 54: 35–100
   PubMed Web of Science ®Google Scholar
• Schoenmakers E F, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven W J. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet 1995; 10: 436–444
   PubMed Web of Science ®Google Scholar
• Hennig Y, Rogalla P, Wanschura S, Frey G, Deichert U, Bartnitzke S, et al. HMGIC expressed in a uterine leiomyoma with a deletion of the long arm of chromosome 7 along with a 12q14-15 rearrangement but not in tumors showing del(7) as the sole cytogenetic abnormality. Cancer Genet Cytogenet 1997; 96: 129–133
   PubMed Web of Science ®Google Scholar
• Gattas G J, Quade B J, Nowak R A, Morton C C. HMGIC expression in human adult and fetal tissues and in uterine leiomyomata. Genes Chromosomes Cancer 1999; 25: 316–322
   PubMed Web of Science ®Google Scholar
• Ashar H R, Fejzo M S, Tkachenko A, Zhou X, Fletcher J A, Weremowicz S, et al. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 1995; 82: 57–65
   PubMed Web of Science ®Google Scholar
• Rogalla P, Drechsler K, Frey G, Hennig Y, Helmke B, Bonk U, et al. HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am J Pathol 1996; 149: 775–779
   PubMed Web of Science ®Google Scholar
• Hirning-Folz U, Wilda M, Rippe V, Bullerdiek J, Hameister H. The expression pattern of the Hmgic gene during development. Genes Chromosomes Cancer 1998; 23: 350–357
   PubMed Web of Science ®Google Scholar
• Zhou X, Benson K F, Ashar H R, Chada K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 1995; 376: 771–774
   PubMed Web of Science ®Google Scholar
• Battista S, Fidanza V, Fedele M, Klein-Szanto A J, Outwater E, Brunner H, et al. The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res 1999; 59: 4793–4797
   PubMed Web of Science ®Google Scholar
• Ligon A H, Moore S D, Parisi M A, Mealiffe M E, Harris D J, Ferguson H L, et al. Constitutional rearrangement of the architectural factor HMGA2: a novel human phenotype including overgrowth and lipomas. Am J Hum Genet 2005; 340–348
   PubMed Web of Science ®Google Scholar
• Miyazawa J, Mitoro A, Kawashiri S, Chada K K, Imai K. Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity. Cancer Res 2004; 64: 2024–2029
   PubMed Web of Science ®Google Scholar
• Rogalla P, Drechsler K, Kazmierczak B, Rippe V, Bonk U, Bullerdiek J. Expression of HMGI-C, a member of the high mobility group protein family, in a subset of breast cancers: relationship to histologic grade. Mol Carcinog 1997; 19: 153–156
   PubMed Web of Science ®Google Scholar
• Abe N, Watanabe T, Suzuki Y, Matsumoto N, Masaki T, Mori T, et al. An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue. Br J Cancer 2003; 89: 2104–2109
   PubMed Web of Science ®Google Scholar
• Rogalla P, Drechsler K, Schroder-Babo W, Eberhardt K, Bullerdiek J. HMGIC expression patterns in non-small lung cancer and surrounding tissue. Anticancer Res 1998; 18: 3327–3330
   PubMed Web of Science ®Google Scholar
• Meyer B, Loeschke S, Schultze A, Weigel T, Sandkamp M, Goldmann T, et al. HMGA2 overexpression in non-small cell lung cancer. Mol Carcinog 2007; 46: 503–511
   PubMed Web of Science ®Google Scholar
• Langelotz C, Schmid P, Jakob C, Heider U, Wernecke K D, Possinger K, et al. Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer. Br J Cancer 2003; 88: 1406–1410
   PubMed Web of Science ®Google Scholar
• Sezer O, Langelotz C, Blohmer J U, Schmid P, Akrivakis K, Possinger K. Detection of HMGI-C in the peripheral blood of breast cancer patients. Eur J Cancer 2000; 36: 1944–1948
   PubMed Web of Science ®Google Scholar
• Fabjani G, Tong D, Wolf A, Roka S, Leodolter S, Hoecker P, et al. HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer. Oncol Rep 2005; 14: 737–741
   PubMed Web of Science ®Google Scholar
• Rommel B, Rogalla P, Jox A, Kalle C V, Kazmierczak B, Wolf J, et al. HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells. Leuk Lymphoma 1997; 26: 603–607
   PubMed Web of Science ®Google Scholar
• Patel H S, Kantarjian H M, Bueso-Ramos C E, Medeiros L J, Haidar M A. Frequent deletions at 12q14.3 chromosomal locus in adult acute lymphoblastic leukemia. Genes Chromosomes Cancer 2005; 42: 87–94
   PubMed Web of Science ®Google Scholar
• Santulli B, Kazmierczak B, Napolitano R, Caliendo I, Chiappetta G, Rippe V, et al. A 12q13 translocation involving the HMGI-C gene in richter transformation of a chronic lymphocytic leukemia. Cancer Genet Cytogenet 2000; 119: 70–73
   PubMed Web of Science ®Google Scholar
• Pierantoni G M, Santulli B, Caliendo I, Pentimalli F, Chiappetta G, Zanesi N, et al. HMGA2 locus rearrangement in a case of acute lymphoblastic leukemia. Int J Oncol 2003; 23: 363–367
   PubMed Web of Science ®Google Scholar
• Andrieux J, Demory J L, Dupriez B, Quief S, Plantier I, Roumier C, et al. Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia. Genes Chromosomes Cancer 2004; 39: 82–87
   PubMed Web of Science ®Google Scholar
• Odero M D, Grand F H, Iqbal S, Ross F, Roman J P, Vizmanos J L, et al. Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies. Leukemia 2005; 19: 245–252
   PubMed Web of Science ®Google Scholar
• Kottickal L V, Sarada B, Ashar H, Chada K, Nagarajan L. Preferential expression of HMGI-C isoforms lacking the acidic carboxy terminal in human leukemia. Biochem Biophys Res Commun 1998; 242: 452–456
   PubMed Web of Science ®Google Scholar
• Inoue N, Izui-Sarumaru T, Murakami Y, Endo Y, Nishimura J I, Kurokawa K, et al. Molecular basis of clonal expansion of hematopoiesis in two patients with paroxysmal nocturnal hemoglobinuria (PNH). Blood 2006; 108: 4232–4236
   PubMed Web of Science ®Google Scholar
• Guglielmelli P, Zini R, Bogani C, Salati S, Pancrazzi A, Bianchi E, et al. Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilm's tumor gene (WT1). Stem Cells 2007; 25: 165–173
   PubMed Web of Science ®Google Scholar
• Hochhaus A, Berger U, Reiter A, Engelich G, Lahaye T, Kreil S, et al. [Current therapy concepts in chronic myeloid leukemia. Study IV of the German CML Study Group]. Internist 2002; 43: 1228–1244
   PubMed Web of Science ®Google Scholar
• Gross K L, Neskey D M, Manchanda N, Weremowicz S, Kleinman M S, Nowak R A, et al. HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies. Genes Chromosomes Cancer 2003; 38: 68–79
   PubMed Web of Science ®Google Scholar
• Clarkson B D, Strife A, Wisniewski D, Lambek C, Carpino N. New understanding of the pathogenesis of CML: a prototype of early neoplasia. Leukemia 1997; 11: 1404–1428
   PubMed Web of Science ®Google Scholar
• Hehlmann R, Berger U, Hochhaus A. Chronic myeloid leukemia: a model for oncology. Ann Hematol 2005; 84: 487–497
   PubMed Web of Science ®Google Scholar
• Manfioletti G, Giancotti V, Bandiera A, Buratti E, Sautiere P, Cary P, et al. cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res 1991; 19: 6793–6797
   PubMed Web of Science ®Google Scholar
• Zhou X, Benson K F, Przybysz K, Liu J, Hou Y, Cherath L, et al. Genomic structure and expression of the murine Hmgi-c gene. Nucleic Acids Res 1996; 24: 4071–4077
   PubMed Web of Science ®Google Scholar
• Boo L M, Lin H H, Chung V, Zhou B, Louie S G, O'Reilly M A, et al. High mobility group A2 potentiates genotoxic stress in part through the modulation of basal and DNA damage-dependent phosphatidylinositol 3-kinase-related protein kinase activation. Cancer Res 2005; 65: 6622–6630
   PubMed Web of Science ®Google Scholar
• Borrmann L, Schwanbeck R, Heyduk T, Seebeck B, Rogalla P, Bullerdiek J, et al. High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity. Nucleic Acids Res 2003; 31: 6841–6851
   PubMed Web of Science ®Google Scholar